StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pacira Pharmaceuticals (PCRX) PT Lowered to $30 at Jefferies
August 1, 2024 3:59 PM
Jefferies analyst Glen Santangelo lowered the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $30.00 (from $36.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Pacira Pharmaceuticals (PCRX) PT Lowered to $37 at RBC Capital
July 31, 2024 6:24 AM
Pacira Pharma (PCRX) Tops Q2 EPS by 20c; offers guidance
July 30, 2024 5:26 PM
Form 10-Q Pacira BioSciences, Inc. For: Jun 30
July 30, 2024 4:03 PM
Form 8-K Pacira BioSciences, Inc. For: Jul 30
July 30, 2024 4:02 PM
Pacira BioSciences Reports Second Quarter 2024 Financial Results
July 30, 2024 4:00 PM
